ANACONDA, INC.
Profile
Company Names
ANACONDA, INC.
CONTINUUM ANALYTICS, INC.
Addresses
206 EAST 9TH STREET, 18TH FLOOR, AUSTIN, TX 78701
221 WEST 6TH STREET, SUITE 1550, AUSTIN, TX 78701
3801 S. CAPITAL OF TEXAS HWY, SUITE 250, AUSTIN, TX 78704
3801 S CAPITAL OF TEXAS HWY, SUITE 250, AUSTIN, TX 78704
400 SADDLEBACK RD, AUSTIN, TX 78737
Phone Numbers
1-512-222-5440
1-512-826-7480
512-222-5440
Entity Type:
CORPORATION
Industry:
OTHER TECHNOLOGY, COMPUTERS
Year Incorporated:
2011
State Incorporated:
DELAWARE
Total Amount Raised:
$18,849,999.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2021-05-07
$2,599,991.00
$2,599,991.00
$0.00
Equity
3
2017-06-27
$10,000,008.00
$10,000,008.00
$0.00
Equity
2
2016-08-18
$4,000,000.00
$10,479,560.00
$6,479,560.00
Equity
1
2011-12-27
$2,250,000.00
$2,250,000.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
GERALD
CHAN
DIRECTOR
CRITICAL BIOLOGICS CORP
| MORNINGSIDE CHINA TMT FUND II, L.P.
| SYNCHRONEURON INC.
| NATURAL POLYMER INTERNATIONAL CORP
| APELLIS PHARMACEUTICALS, INC.
| MORNINGSIDE CHINA TMT FUND III CO-INVESTMENT, L.P.
| MORNINGSIDE CHINA TMT SPECIAL OPPORTUNITY FUND, L.P.
| MORNINGSIDE CHINA TMT FUND III, L.P.
| MORNINGSIDE CHINA TMT TOP UP FUND LP
| MORNINGSIDE CHINA TMT FUND IV CO-INVESTMENT, L.P.
| MORNINGSIDE CHINA TMT SPECIAL OPPORTUNITY FUND II, L.P.
| MORNINGSIDE CHINA TMT FUND IV, L.P.
| ATEA PHARMACEUTICALS, INC.
| GOOD FOODIE CO
| KEZAR LIFE SCIENCES, INC.
| APNIMED, INC.
| STAVROS TECHNOLOGIES, INC.
| STEALTH BIOTHERAPEUTICS CORP
| LUMIRADX LTD
| LINUS HEALTH, INC.
| ANACONDA, INC.
| NEUTROLIS INC.
| COGNITO THERAPEUTICS LTD.
| COGNITO THERAPEUTICS GROUP, INC.
DONALD
FISCHER
DIRECTOR
MATTHEW
HARWARD
EXECUTIVE OFFICER
TRAVIS
OLIPHANT
EXECUTIVE OFFICER, DIRECTOR
TRAVIS
E
OLIPHANT
EXECUTIVE OFFICER, DIRECTOR
PETER
WANG
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

